Genix Pharmaceuticals Corporation Receives Natural Product Number for Rechlor from Health Canada
Vancouver, British Columbia, September 08, 2021 – Genix Pharmaceuticals Corporation (TSX-V: GENX; OTCQB: GENPF)…
Genix Pharmaceuticals Corp. Receives Approval for Drug Establishment License
Vancouver, British Columbia, July 15th, 2021 – Genix Pharmaceuticals Corporation (TSX-V:…
Genix Pharmaceuticals Corp. Lists on the OTCQB Venture Market Exchange
Vancouver, British Columbia, June 21st, 2021 – Genix Pharmaceuticals Corporation…
Genix Pharmaceuticals Corporation Provides a Corporate Update To Shareholders
VANCOUVER, June 07, 2021 – Genix Pharmaceuticals Corporation (TSXV: GENX)…
Genix Pharmaceuticals Corp. Announces AGM Results and Appoints Mahmoud Aziz to the Board and as President
Vancouver, British Columbia, May 20, 2021 — Genix Pharmaceuticals Corporation (TSX-V:…
Genix Pharmaceuticals Corporation Enters into Exclusive License and Supply Agreement for Canada’s First Generic Thyroid Medication
Vancouver, British Columbia, April 1, 2021 – Genix Pharmaceuticals Corporation…